SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001104659-24-025819
Filing Date
2024-02-21
Accepted
2024-02-21 08:13:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B2 tm246099-1_424b2.htm 424B2 876359
2 GRAPHIC lg_astrazeneca-4c.jpg GRAPHIC 16054
  Complete submission text file 0001104659-24-025819.txt   900411
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-256406 | Film No.: 24656447
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1209 ORANGE STREET WILMINGTON DE 19801
Business Address 1209 ORANGE STREET WILMINGTON DE 19801 1-800-677-3394
AstraZeneca Finance LLC (Filer) CIK: 0001862005 (see all company filings)

IRS No.: 000000000
Type: 424B2 | Act: 33 | File No.: 333-256406-01 | Film No.: 24656448
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)